Facebook: Q3 Earnings Preview

Facebook (NASDAQ: FB) will be reporting its third quarter financial results today after the markets close. Analysts have a consensus $417.22 12-month price target on the company, via a total of 57 analysts, with 19 analysts having strong buy ratings. 29 analysts meanwhile have buy ratings, 7 have hold ratings, and two analysts have sell ratings on the company. The street high comes from Credit Suisse with a $500 price target, and the lowest target sits at $225 from Societe Generale.

39 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 39 analysts is $29.56 billion; this number has been revised upwards from $26.71 at the start of April. The highest revenue estimate is $30.19 billion, while the lowest is $28 billion.

Onto EBITDA estimates, there are currently 25 analysts who have third-quarter EBITDA estimates. The mean is currently $15.57 billion, with this number having been revised upwards from $13.30 billion at the start of april. The street high estimate currently sits at $16.68 billion in EBITDA and the lowest is $14.26 billion.

Analysts estimate that quarterly earnings per share will come in at $3.19, with this number being revised upwards from $2.71 at the start of April. Street high is $3.50 and the lowest estimate is $2.68 per share for the quarter


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Ayr Wellness: Cantor Halves Price Target On Weak Q1 Results

On May 26, Ayr Wellness (CSE: AYR.A) reported its first quarter financial results. The company...

Saturday, May 28, 2022, 05:08:00 PM

Curaleaf Sees Consensus Estimates Stay Flat After Q1 Results

Curaleaf Holdings (CSE: CURA) reported its first-quarter results on May 10th, beating the consensus estimates...

Saturday, May 15, 2021, 04:24:00 PM

Paypal: Analysts Forecast Q2 Revenues Of $6.26 Billion

Paypal (NASDAQ: PYPL) will be reporting its second quarter financial results today after market close....

Wednesday, July 28, 2021, 03:03:00 PM

Jushi Sees Canaccord Reiterate US$10 Price Target After Management Change-up

On June 30th, Jushi Holdings Inc. (CSE: JUSH) announced management and board of director changes....

Sunday, July 4, 2021, 01:09:00 PM

AMD: Analysts Raise Estimates, Markets Shrug Following Earnings

Advanced Micro Devices (NASDAQ: AMD) opened 3% higher but ultimately closed down 1.4% the day...

Friday, April 30, 2021, 03:41:00 PM